Mineralys Therapeutics, Inc. (MLYS) Ownership

$15.62

$0.1 (0.64%)
Last update: 04:00 PM EST
Day's range
$15.27
Day's range
$15.93

Mineralys Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CATALYS PACIFIC, LLC 05/14/2025 8.64 M $141.39 M   0.00% 16.26%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 6.15 M $97.62 M   26.72% 11.56%
SAMSARA BIOCAPITAL, LLC 05/15/2025 5.67 M $90.12 M   11.82% 10.67%
SR ONE CAPITAL MANAGEMENT, LP 05/13/2025 3.13 M $49.67 M   55.09% 5.88%
TCG CROSSOVER MANAGEMENT, LLC 05/14/2025 2.47 M $39.23 M   0.00% 4.65%
BLACKROCK, INC. 05/02/2025 2.45 M $38.91 M   14.57% 4.61%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2025 2.30 M $36.52 M   162.86% 4.33%
CALIGAN PARTNERS LP 05/15/2025 2.15 M $34.14 M   112.60% 4.04%
VANGUARD GROUP INC 05/09/2025 2.04 M $32.32 M   42.14% 3.83%
JENNISON ASSOCIATES LLC 05/05/2025 1.98 M $31.43 M   82.90% 3.72%
LAURION CAPITAL MANAGEMENT LP 05/15/2025 1.90 M $30.14 M   34.40% 3.57%
FRANKLIN RESOURCES INC 05/13/2025 1.78 M $28.27 M   1.97% 3.35%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2025 1.67 M $26.48 M   100.00% 3.14%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 1.21 M $19.28 M   100.00% 2.28%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 1.10 M $17.47 M   214.29% 2.07%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 923.40 K $14.66 M   42.06% 1.74%
CANDRIAM S.C.A. 05/14/2025 882.83 K $14.02 M   189.20% 1.66%
AMERICAN CENTURY COMPANIES INC 05/13/2025 823.62 K $13.08 M   -2.95% 1.55%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 802.00 K $12.74 M   29.35% 1.51%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2025 787.74 K $12.51 M   24.54% 1.48%
MORGAN STANLEY 05/15/2025 619.75 K $9.84 M   5.14% 1.17%
STATE STREET CORP 05/15/2025 520.18 K $8.26 M   3.10% 0.98%
D. E. SHAW & CO., INC. 05/15/2025 478.43 K $7.60 M   100.00% 0.90%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2025 465.53 K $7.39 M   144.15% 0.88%
22NW, LP 05/14/2025 461.34 K $7.33 M   100.00% 0.87%
MILLENNIUM MANAGEMENT LLC 05/15/2025 424.69 K $6.74 M   -61.45% 0.80%
FINDELL CAPITAL MANAGEMENT LLC 05/15/2025 400.00 K $6.35 M   100.00% 0.75%
PALE FIRE CAPITAL SE 05/14/2025 399.50 K $6.34 M   191.82% 0.75%
SECTORAL ASSET MANAGEMENT INC 05/15/2025 370.51 K $5.88 M   -2.72% 0.70%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2025 338.35 K $5.37 M   100.00% 0.64%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 320.81 K $5.09 B   100.00% 0.60%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 309.20 K $4.91 M   111.06% 0.58%
INVESCO LTD. 05/12/2025 308.31 K $4.90 M   100.00% 0.58%
FMR LLC 05/12/2025 304.76 K $4.84 M   0.19% 0.57%
GOLDMAN SACHS GROUP INC 05/16/2025 298.40 K $4.74 M   166.63% 0.56%
DEUTSCHE BANK AG\ 05/09/2025 296.02 K $4.70 M   1,007.34% 0.56%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2025 293.93 K $4.67 M   100.00% 0.55%
CANADA PENSION PLAN INVESTMENT BOARD 05/15/2025 279.50 K $4.44 M   100.00% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 270.18 K $4.29 M   25.72% 0.51%
NORTHERN TRUST CORP 05/13/2025 265.06 K $4.21 M   7.70% 0.50%
ADAR1 CAPITAL MANAGEMENT, LLC 05/15/2025 263.43 K $4.18 M   -68.70% 0.50%
CAPTION MANAGEMENT, LLC 05/15/2025 247.70 K $3.93 M   100.00% 0.47%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 217.46 K $3.45 M   100.00% 0.41%
BLUE OWL CAPITAL HOLDINGS LP 05/15/2025 206.30 K $3.28 M   100.00% 0.39%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 200.00 K $3.18 M   100.00% 0.38%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 200.00 K $3.18 M   100.00% 0.38%
J. GOLDMAN & CO LP 05/15/2025 178.30 K $2.83 M   100.00% 0.34%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 177.30 K $2.82 M   48.37% 0.33%
EAM INVESTORS, LLC 05/13/2025 164.27 K $2.61 M   100.00% 0.31%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2025 150.60 K $2.39 M   100.00% 0.28%

Mineralys Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 160 institutional investors and hedge funds held shares of Mineralys Therapeutics, Inc.. The most heavily invested institutionals were:

Catalys Pacific, LLC: 8.64 M

RA CAPITAL MANAGEMENT, L.P.: 6.15 M

Samsara BioCapital, LLC: 5.67 M

SR ONE CAPITAL MANAGEMENT, LP: 3.13 M

TCG Crossover Management, LLC: 2.47 M

BlackRock, Inc.: 2.45 M

113.97% of Mineralys Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 63.11 M shares in the last 24 months. This purchase volume represents approximately $992.68 M in transactions.